Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study of real-world effectiveness of Ig replacement for hypogammaglobulinemia and infections in myeloma finds it is associated with significant reductions in both (infxn (OR [95% CI]: 0.71 [0.56, 0.89], P=0.0004)).”
Title: Real-world effectiveness of immunoglobulin replacement for hypogammaglobulinemia and infections in multiple myeloma
Authors: Elizabeth O’Donnell, Thais Gift, Zaid Yousif, Nikhil Khandelwal, Raj Desai, Lynn Huynh, Louise Clear, Megan Pinaire, Mingchen Ye, Azeem Banatwala, Gregory Belsky, Yichuan Grace Hsieh, Christopher Herrick, Mei Sheng Duh, Shawn Murphy, Marie Sanchirico.
You can read the Full Article on Blood Advances.
More posts featuring Robert Orlowski.